Figure 3: A) Percent reduction in proteinuria. Combination therapy resulted in an additional 27% relative reduction in proteinuria compared to monotherapy. B) Combination therapy with an ACEI and ARB vs. monotherapy led to further 25% reduction in proteinuria. C) Combination therapy with an ALDOA plus an ACEI or ARB vs. ACEI or ARB alone led to 32% further reduction in proteinuria.